Overview

Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).

Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
0
Participant gender:
All
Summary
Compare different corneal parameters and visual outcome of corneal collagen cross-linking (CXL) with conventional versus accelerated ultraviolet-A irradiation using riboflavin with hydroxypropyl methylcellulose.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Riboflavin
Criteria
Inclusion Criteria:

- Patients with increase of minimum of 1,0 diopter in maximum keratometry.

- Patients with increase in corneal astigmatism of minimum 1,0 diopter.

- Patients with in spherical equivalent of min 0,5 diopter.

- Patients living in Eastern Norway.

Exclusion Criteria:

- Minimum pachymetric corneal thickness (Pentacam)<360 µm.

- Central corneal scar.

- Chemical burn, serious corneal infections and ocular surface diseases.

- Pregnancy.

- Lactation.